Biphasic Regulation of Leukocyte Superoxide Generation by Nitric Oxide and Peroxynitrite*

Abstract

Activation of the NADPH oxidase-derived oxidant burst of polymorphonuclear leukocytes (PMNs) is of critical importance in inflammatory disease. PMN-derived superoxide (O⨪2) can be scavenged by nitric oxide (NO) with the formation of peroxynitrite (ONOO); however, questions remain regarding the effects and mechanisms by which NO and ONOO modulate the PMN oxidative burst. Therefore, we directly measured the dose-dependent effects of NOand ONOO on O⨪2 generation from human PMNs stimulated with phorbol 12-myristate 13-acetate using EPR spin trapping. Pretreatment with low physiological (μm) concentrations of NO from NO gas had no effect on PMN O⨪2 generation, whereas high levels (≥50 μm) exerted inhibition. With ONOO pretreatment, however, a biphasic modulation of O⨪2 generation was seen with stimulation by μm levels, but inhibition at higher levels. With the NO donor NOR-1, which provides more sustained release of NO persisting at the time of O⨪2 generation, a similar biphasic modulation of O⨪2 generation was seen, and this was inhibited by ONOO scavengers. The enhancement of O⨪2 generation by low concentrations of ONOO or NOR-1 was associated with activation of the ERK MAPKs and was blocked by their inhibition. Thus, low physiological levels of NOpresent following PMN activation are converted to ONOO, which enhances O⨪2 generation through activation of the ERK MAPK pathway, whereas higher levels of NO or ONOOfeed back and inhibit O⨪2 generation. This biphasic concentration-dependent regulation of the PMN oxidant burst by NO-derived ONOO may be of critical importance in regulating the process of inflammation.

Footnotes

  • * This work was supported by National Institutes of Health Grants HL-38324 and HL-63744.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • To whom correspondence should be addressed: EPR Center, Johns Hopkins Asthma and Allergy Center, 5501 Johns Hopkins Bayview Circle, Baltimore, MD 21224. Tel.: 410-550-0339; Fax: 410-550-2448; E-mail: jzweier@welch.jhu.edu.

  • Published, JBC Papers in Press, September 6, 2000, DOI 10.1074/jbc.M006341200

  • Abbreviations:
    PMNs

    polymorphonuclear leukocytes

    O⨪2

    superoxide

    NO

    nitric oxide

    ONOO

    peroxynitrite

    MAPK

    mitogen-activated protein kinase

    ERK

    extracellular signal-regulated kinase

    MEK

    MAPK/ERK kinase

    DEPMPO

    5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide

    PIPES

    1,4-piperazinediethanesulfonic acid

    PMA

    phorbol 12-myristate 13-acetate

    FeTMPS

    5,10,15,20-tetrakis(2,4,6-trimethyl-3,3-disulfonatophenyl)porphyrinato iron(III)

    • Received July 18, 2000.
    • Revision received September 5, 2000.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement